novelty pharma gdd sa
Novelty Pharma - Innovazione farmaceutica Effervescente
발포성 제약 혁신 회사에 대한 추가 정보 우리는 25년 넘게 의약품과 식품 보조제를 개발해 왔습니다. 우리는 미래를 예측한다는 사명을 가지고 제약, 영양, 화장품을 전문으로 하는 의료 부문의 우수 센터입니다. 시장 동향에 대한 끊임없는 관심 덕분에 우리는 혁신을 주도하고 최첨단 제품을 만듭니다.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Cadempino, Switzerland
- Website
- https://www.noveltypharma.com
- Categories
- 의약품 제조, 의료 및 건강 관리 용품, 보충제 및 웰니스
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-02 Domain registry record
- web-presence-since (green), checked 2026-08-03 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-07-21 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)